Pulmonary arteriole (PA)

Pulmonary arterioles are small, precapillary blood vessels in the lungs that play a vital role in regulating pulmonary blood flow and vascular resistance. These vessels are characterized by a thin layer of smooth muscle cells and an endothelial lining, which respond to various local and systemic signals to maintain hemodynamic balance (StatPearls, "Physiology, Pulmonary Vascular Resistance"). A unique feature of pulmonary arterioles is hypoxic pulmonary vasoconstriction, a mechanism that redirects blood flow away from poorly ventilated alveoli to optimize gas exchange. In diseases such as pulmonary arterial hypertension (PAH), these arterioles undergo pathological remodeling, including intimal fibrosis and medial hypertrophy, which narrows the vessel lumen and increases blood pressure (NIH, "Pulmonary Hypertension"). Although they are not a single molecular target, pulmonary arterioles serve as the primary site of action for various therapeutic agents, including phosphodiesterase-5 inhibitors and endothelin receptor antagonists (PubMed, PMID: 30165842). These drugs act on specific receptors and enzymes within the arteriolar wall to induce vasodilation and inhibit the proliferation of vascular cells. Consequently, maintaining the functional integrity and diameter of pulmonary arterioles is the central goal of most pulmonary vasodilator therapies.

Other names

Pulmonary resistance vesselSmall pulmonary arteryPrecapillary pulmonary vessel

Pharmacological intervention at the pulmonary arteriole level typically involves inducing vasodilation and inhibiting vascular remodeling by targeting molecular pathways within the vascular smooth muscle and endothelial cells, such as the nitric oxide, endothelin, and prostacyclin pathways.